Stroke

Cardiovascular departments are playing a role in stroke interventions at numerous health systems, working as part of the stroke care team with neurologists, radiology and the emergency department. Stroke first has be be classified as ischemic or hemorrhagic. These have very different care pathways. Ischemic strokes are increasingly being treated with neurological-interventional therapy that includes catheter based mechanical thrombectomy to remove the clot. This is a more aggressive treatment compared to traditional IV administration of tissue plasminogen activator (tPA) thrombolytic therapy to dissolve the clot. Subarachnoid hemorrhage (SAH) and  intracerebral hemorrhage (ICH) brain bleeds can also be treated in some cases stent flow diverters and embolization coils. 

Product Recall

FDA announces new recall of neurovascular catheters built by Johnson & Johnson subsidiary

The recall is due to ongoing concerns about the devices breaking. Three patients have been injured as a result of this issue.

April 4, 2024
Avicenna.AI, a French artificial intelligence (AI) startup co-founded by a radiologist, has received U.S. Food and Drug Administration (FDA) clearance for two new offerings designed to automatically identify cardiovascular findings in CT scans, CINA-iPE and CINA-ASPECTS.

Radiology AI company gains FDA clearance for new CT offerings focused on PE, stroke

The newly approved AI models are designed to improve the detection of pulmonary embolisms and strokes in patients who undergo CT scans.

March 26, 2024
The rapid rise of artificial intelligence (AI) has helped cardiologists, radiologists, nurses and other healthcare providers embrace precision medicine in a way that ensures more heart patients are receiving personalized care.

AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do

A new scientific statement from the American Heart Association explores the many ways AI and machine learning are being used to improve care for heart patients.

March 7, 2024
Video - Ken Rosenfield, MD, MGH, and William Gray, MD, Lankenau Heart, explain impact of new CMS coverage for carotid stenting.

How a big CMS update on carotid stenting could impact interventional cardiology

Ken Rosenfield, MD, of Massachusetts General Hospital, and William Gray, MD, of Lankenau Heart Institute, detailed the long-term impact of a key policy shift. 

March 5, 2024
Marijuana use among older adults is associated with a heightened risk of atrial and ventricular arrhythmias, according to new research published in the American Journal of Cardiology. “Marijuana use increases sympathetic nervous system activity and inhibits cardiac parasympathetic innervation, resulting in elevated heart rate, elevated blood pressure, and an increase in myocardial oxygen demand.

‘Just like smoking tobacco’: Cannabis use increases stroke risk by 42%, heart attack risk by 25%

“It can be a challenging discussion to have with patients because there is evidence that cannabis has some therapeutic properties," one researcher said. "However, as suggested by this study, cannabis use also has significant cardiovascular risks.”  

March 4, 2024
Image of the Royal Philips Azurion neuro biplane system

Philips announces new Azurion update focused on improving care for stroke patients

According to Philips, this latest update makes the Azurion image-guided therapy platform more efficient than ever.

February 27, 2024
Using the Sentinel cerebral protection device during valve-in-valve TAVR is associated with significant clinical improvements.

Cerebral protection devices during valve-in-valve TAVR: Cleveland Clinic cardiologists identify key benefits

Cerebral protection devices, designed to limit the risk of stroke during transcatheter aortic valve replacement, may be especially helpful when patients undergo valve-in-valve TAVR.

February 26, 2024
artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).

FDA clears advanced AI model for detecting, quantifying bleeding strokes

The new algorithm from Viz.ai is capable of identifying, labeling and quantifying brain bleeds in noncontrast CT images.

February 9, 2024

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup